Researchers across the world have been trying for years to develop a portable
blood substitute that functions as an oxygen carrier, is stable enough to be stored for a prolonged period in different conditions and can be used to treat individuals of any blood type but haven't been successful so far.
According to Kundu, researchers across the world have been trying for years to develop a portable
blood substitute that functions as an oxygen carrier, is stable enough to be stored for prolonged periods in different conditions and can be used to treat individuals of any blood type but haven't been successful so far due to one shortcoming.
Administering a
blood substitute may benefit the patient by simulating the properties of a blood transfusion.
Initial attempts at creating a
blood substitute from hemoglobin alone have been hampered by several factors.
In addition, possible clinical and therapeutic applications for a viable
blood substitute include, for example, massive hemorrhage and hemorrhagic shock caused by accidents and wars.
A "NO-CONSENT" MEDICAL STUDY of an experimental
blood substitute is creating an uproar among researchers and bioethicists.
HemoBioTech has a worldwide exclusive license to HemoTech, which is being developed as a
blood substitute.
There was still time for Slemen to trade penalties with rookie James King, who had come on as a
blood substitute for MacRae.
Northfield Laboratories, Inc., Evanston, IL, has received a recommendation from an independent data monitoring committee (IDMC) that the company continue its pivotal Phase 3 study of PolyHeme, the company's human hemoglobin-based
blood substitute, without modification.
Biopure Corp., for example, has admitted that it might be sued by the SEC for statements concerning prospects of Hemopure, its artificial
blood substitute. Shares of that firm have also fallen significantly amid speculation that the FDA will not approved Hemopure.
Northfield Laboratories Inc., Evanston, Ill., (NASDAQ: NFLD) has received clearance to begin patient enrollment in its pivotal Phase III urban ambulance trial with PolyHeme(r), the company's oxygen-carrying
blood substitute.
Another innovative medical project now being worked separately by the Army and the Navy, Cowan continued, involves the development of a dehydrated
blood substitute that can be reconstituted with sterile water in the field.